in follow up to George re Biogen,
...and consequently, in the few days after this announcement from Biogen, over 4B USD was added to their market cap. (with only 330 people with the disease in the US) Meanwhile, Sarepta currently rake a billion in sales from just 30% of the DMD market with no real efficacy found from their drugs. And here we are under $100M MC.
in follow up to George re Biogen, ...and consequently, in the...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $101.7K | 1.017M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43179 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 48202 | 2 |
View Market Depth
| Last trade - 13.26pm 26/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |